Similar articles

• Effect of hypertonic saline on cerebral blood flow in poor-grade patients with subarachnoid hemorrhage.

  Tseng MY, Al-Rawi PG, Pickard JD, Rasulo FA, Kirkpatrick PJ. Tseng MY, et al. Stroke. 2003 Jun;34(6):1389-96. doi: 10.1161/01.STR.0000071526.45277.44. Epub 2003 May 1. Stroke. 2003. PMID: 12730557
• Cerebral blood flow augmentation in patients with severe subarachnoid haemorrhage.

  Al-Rawi PG, Zygun D, Tseng MY, Hutchinson PJ, Matta BF, Kirkpatrick PJ. Al-Rawi PG, et al. Acta Neurochir Suppl. 2005;95:123-7. doi: 10.1007/3-211-32318-x_27. Acta Neurochir Suppl. 2005. PMID: 16463835 Clinical Trial.
• Early Administration of Hypertonic-Hyperoncotic Hydroxyethyl Starch (HyperHES) Improves Cerebral Blood Flow and Outcome After Experimental Subarachnoid Hemorrhage in Rats.

  Lilla N, Rinne C, Weiland J, Linsenmann T, Ernestus RI, Westermaier T. Lilla N, et al. World Neurosurg. 2018 Aug;116:e57-e65. doi: 10.1016/j.wneu.2018.03.205. Epub 2018 Apr 5. World Neurosurg. 2018. PMID: 29627628
• Endovascular therapy for vasospasm.

  Srinivasan J, Eskridge J, Grady MS, Newell DW, Winn HR. Srinivasan J, et al. Clin Neurosurg. 2002;49:261-73. Clin Neurosurg. 2002. PMID: 12506559 Review. No abstract available.
• Blood pressure management in patients with intracerebral and subarachnoid hemorrhage.

  Mocco J, Rose JC, Komotar RJ, Mayer SA. Mocco J, et al. Neurosurg Clin N Am. 2006 Sep;17 Suppl 1:25-40. doi: 10.1016/s1042-3680(06)80005-7. Neurosurg Clin N Am. 2006. PMID: 17967691 Review. No abstract available.